Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GoodBelly, operated by NextFoods, is a functional food and beverage company specializing in probiotic products designed to support digestive health. Founded by the creators of Silk Soymilk, the company utilizes the well-documented probiotic strain Lactobacillus plantarum 299v (LP299V), which has been extensively researched for its ability to survive the stomach's acidic environment and colonize the intestinal tract. Their product portfolio includes probiotic juices, shots, supplements, and snacks aimed at improving gut health and overall wellness. GoodBelly positions itself at the intersection of nutrition and biotechnology, leveraging clinical research to validate the efficacy of its probiotic delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GoodBelly.